My watch list
my.chemeurope.com  
Login  

Protein kinase Mζ




Protein kinase C, zeta
Identifiers
Symbol(s) PRKCZ; PKC2
External IDs OMIM: 176982 MGI: 97602 Homologene: 55681
EC number 2.7.1.37
RNA expression pattern

Additional recommended knowledge

More reference expression data

Orthologs
Human Mouse
Entrez 5590 18762
Ensembl ENSG00000067606 ENSMUSG00000029053
Uniprot Q05513 Q3UHM5
Refseq NM_001033581 (mRNA)
NP_001028753 (protein)
NM_001039079 (mRNA)
NP_001034168 (protein)
Location Chr 1: 1.97 - 2.11 Mb Chr 4: 154.1 - 154.21 Mb
Pubmed search [1] [2]

Protein kinase Mζ (also called PKMζ or PKMzeta) is the independent catalytic domain of protein kinase Cζ and, lacking an autoinhibitory regulatory domain of the full-length PKCζ, is constitutively active. This constitutive or autonomous activity allows the kinase to be independent of second messengers and thus persistently active. It was originally thought of as being a cleavage product of full-length PKCζ, an atypical isoform of protein kinase C (PKC). Like other PKC isoforms, PKCζ is a serine/threonine kinase that adds phosphate groups to target proteins. It is atypical in that unlike other PKC isoforms, PKCζ does not require calcium or diacylglycerol (DAG) to become active, but rather relies on a second messenger other than DAG, presumably generated through a phosphoinositide 3-kinase (PI3-kinase) pathway. It is now known that PKMζ is not the result of cleavage of full-length PKCζ, but rather, in mammalian brain, is translated from its own brain-specific mRNA, that is transcribed from the full-length PKCζ gene.[1] The promotor for full-length PKCζ is largely inactive in the forebrain and so PKMζ is the dominant form of ζ in the forebrain and the only PKM that is translated from its own mRNA.

PKMζ is thought to be responsible for maintaining the late phase of long-term potentiation.[2][3][4] This theory arose from the observation that PKMζ perfused postsynaptically into neurons causes synaptic potentiation and selective inhibitors of PKMζ, when bath applied 1 hr after tetanization, inhibit the late phase or maintenance of LTP. Thus PKMζ is both necessary and sufficient for maintaining LTP. Subsequent work showed that inhibiting the kinase reversed LTP maintenance when applied up to 5 hours after LTP was induced in hippocampal slices, and after 22 hr in vivo. Inhibiting PKMζ in behaving animals erased spatial long-term memories in the hippocampus that were up to 1 month-old, without affecting spatial short-term memories.[4] In the neocortex, thought to be the site of storage for most long-term memories, PKMζ inhibition erased memories for conditioned taste aversion in the insular cortex.[5] PKMζ is thus the first molecule shown to be a component of the storage mechanism of long-term memory.

References

  1. ^ Hernandez AI, Blace N, Crary JF, Serrano PA, Leitges M, Libien JM, Weinstein G, Tcherapanov A, Sacktor TC. (2003). "Protein kinase M zeta synthesis from a brain mRNA encoding an independent protein kinase C zeta catalytic domain. Implications for the molecular mechanism of memory.". J. Biol. Chem. 278 (41): 40305-16. PMID 12857744.
  2. ^ Ling D, Benardo L, Serrano P, Blace N, Kelly M, Crary J, Sacktor T (2002). "Protein kinase Mzeta is necessary and sufficient for LTP maintenance". Nat. Neurosci. 5 (4): 295-6. PMID 11914719.
  3. ^ Serrano P, Yao Y, Sacktor T (2005). "Persistent phosphorylation by protein kinase Mzeta maintains late-phase long-term potentiation". J Neurosci 25 (8): 1979-84. PMID 15728837.
  4. ^ a b Pastalkova E, Serrano P, Pinkhasova D, Wallace E, Fenton A, Sacktor T (2006). "Storage of spatial information by the maintenance mechanism of LTP". Science 313 (5790): 1141-4. PMID 16931766.
  5. ^ Shema R, Sacktor T, Dudai Y (2007). "Rapid erasure of long-term memory associations in the cortex by an inhibitor of PKMζ". Science 317 (5840): 951-3. PMID 17702943.

Further reading

  • Slater SJ, Ho C, Stubbs CD (2003). "The use of fluorescent phorbol esters in studies of protein kinase C-membrane interactions.". Chem. Phys. Lipids 116 (1-2): 75-91. PMID 12093536.
  • Carter CA, Kane CJ (2005). "Therapeutic potential of natural compounds that regulate the activity of protein kinase C.". Curr. Med. Chem. 11 (21): 2883-902. PMID 15544481.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Protein_kinase_Mζ". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE